LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lab-on-a-Chip Technology Requires Standardization

By LabMedica International staff writers
Posted on 23 Aug 2012
Print article
Testing standards need to be developed and implemented before Lab-on-a-Chip (LOC) technology can be fully commercialized.

LOC devices are microchip-size systems, that can prepare and analyze tiny fluid samples with volumes ranging from a few microliters to sub-nanoliters, are envisioned to one day revolutionize how laboratory tasks such as diagnosing diseases are performed.

Physical scientists at the US National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) have suggested that standardized testing and measurement methods, will enable microelectromechanical systems (MEMS) LOC manufacturers at all stages of production, from processing of raw materials to final rollout of products, to accurately determine important physical characteristics of LOC devices such as dimensions, electrical surface properties, and fluid flow rates and temperatures.

To make the case for testing standards, the scientists have focused on autofluorescence, the background fluorescent glow of an LOC device that can interfere with the analysis of a sample. Multiple factors must be considered in the development of a testing standard for autofluorescence, including the materials used in the device, the measurement methods used to test the device, and how the measurements are interpreted. This material property of microfluidic and nanofluidic devices is of increasing importance due to the growing interest in sensitive fluorescence measurements performed in chips fabricated from plastics

Samuel M. Stavis, PhD, the author of the study, said: "Quality control during LOC device manufacturing may require different tests of autofluorescence throughout the process. There may be one measurement of autofluorescence from the block of plastic that is the base material for a chip, another once the block has been fashioned into the substrate in which the functional components are embedded, and yet another as the final device is completed. To manufacture lab on a chip devices with reliably low autofluorescence, accurate measurements may be needed at each stage."

Dr. Stavis emphasizes that it is important not to confuse testing standards with product standards, and to understand how the former facilitates the latter. He added, "A product standard specifies the technical requirements for a lab-on-a-chip device to be rated as top quality. A testing standard is needed to measure those specifications, as well as to make fair comparisons between competing products." The study was published on June 28, 2012, in the journal Lab on A Chip.

Related Links:

US National Institute of Standards and Technology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more